ask why
Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

The papers that matter: 20 October to 26 October 2025

The 10 most important of the 14 papers published that week and summarised on Y, ranked by what verified readers said would change practice, then by strength of design and size. Secondary analyses come last.
Public health and primary care · Fam Pract · 2025-10-21

Secondary cost-effectiveness analysis of a Dutch primary care trial in 183 patients with shoulder pain: exercise therapy vs corticosteroid injection gave an ICER of EUR 14,489 per QALY over 12 months, with a 70% probability of being cost-effective at EUR 50,000/QALY.

RCTn = 183
Versloot et al. Cost-effectiveness of a corticosteroid injection versus exercise therapy for shoulder pain in general practice (SIX-Shoulder Study): a randomized controlled trial
Public health and primary care · Fam Pract · 2025-10-21

In a cluster randomised trial of 180 patients with diabetes at six Beijing community health centres, personalised CAPDCA education versus traditional education achieved HbA1c target more often over 18 months (83.3% vs 25.0%; RR 3.33), with greater HbA1c reduction.

RCTn = 180
Li et al. Effect of collection-assessment-plan-do-check-aggrandizement model of personalized patient education in patients with diabetes: a cluster randomized controlled study
Infectious diseases · Int J Infect Dis · 2025-10-24

Meta-analysis of 167 studies of syphilis serology: treponemal test positivity was 89.26% in primary, 97.43% secondary, 94.18% latent and 93.83% tertiary syphilis; nontreponemal positivity ranged 71.58% to 96.69%. Heterogeneity was significant.

Meta-analysisn = 167 studies
Xie et al. Reevaluating serological patterns in syphilis: new insights into the dynamic trend of treponemal and nontreponemal antibodies across disease stages based on a meta-analysis

Previous weekNext weekAll weeks

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.